We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.88B
AUM Growth
-$192M
Cap. Flow
-$389M
Cap. Flow %
-13.48%
Top 10 Hldgs %
24.09%
Holding
2,616
New
690
Increased
430
Reduced
710
Closed
773

Top Buys

Rank Stock Value
1
XPEV icon
XPeng
XPEV
+$75.5M
2
BEKE icon
KE Holdings
BEKE
+$46.5M
3
NTES icon
NetEase
NTES
+$45.4M
4
EDU icon
New Oriental
EDU
+$39.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Consumer Discretionary 7.29%
3 Communication Services 3.78%
4 Financials 3.51%
5 Healthcare 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
1301
Denali Therapeutics
DNLI
$3.97B
$59K ﹤0.01%
1,319
+420
+47% +$19.9K
EEFT icon
1302
Euronet Worldwide
EEFT
$2.7B
$59K ﹤0.01%
+493
New +$58.6K
EOG icon
1303
EOG Resources
EOG
$70.7B
$58K ﹤0.01%
+655
New +$58.8K
MZTI
1304
The Marzetti Company
MZTI
$3.11B
$58K ﹤0.01%
348
-567
-62% -$92.9K
PFSI icon
1305
PennyMac Financial
PFSI
$4.02B
$58K ﹤0.01%
+829
New +$54.7K
MD icon
1306
Pediatrix Medical
MD
$2.2B
$57K ﹤0.01%
+2,085
New +$55.8K
MRSN
1307
DELISTED
Mersana Therapeutics
MRSN
$57K ﹤0.01%
+367
New +$71.4K
OXM icon
1308
Oxford Industries
OXM
$552M
$57K ﹤0.01%
557
+470
+540% +$45.7K
TBI
1309
Trueblue
TBI
$311M
$57K ﹤0.01%
2,067
+1,592
+335% +$45K
PDCO
1310
DELISTED
Patterson Companies, Inc.
PDCO
$57K ﹤0.01%
1,938
+1,037
+115% +$32.5K
FMBI
1311
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$57K ﹤0.01%
2,789
-3,367
-55% -$67.4K
CBSH icon
1312
Commerce Bancshares
CBSH
$8.5B
$56K ﹤0.01%
995
+715
+255% +$40.2K
CNNE icon
1313
Cannae Holdings
CNNE
$649M
$56K ﹤0.01%
1,582
-4,404
-74% -$146K
HALO icon
1314
Halozyme
HALO
$12.2B
$56K ﹤0.01%
1,402
+275
+24% +$10.3K
MNKD icon
1315
MannKind Corp
MNKD
$1.32B
$56K ﹤0.01%
12,903
+269
+2% +$1.25K
PRCT icon
1316
Procept Biorobotics
PRCT
$1.17B
$56K ﹤0.01%
2,250
-1,295
-37% -$47.9K
PAR icon
1317
PAR Technology
PAR
$735M
$55K ﹤0.01%
+1,039
New +$62.6K
NUVA
1318
DELISTED
NuVasive, Inc.
NUVA
$55K ﹤0.01%
1,050
-1,089
-51% -$59.2K
CARS icon
1319
Cars.com
CARS
$660M
$54K ﹤0.01%
3,333
-1,422
-30% -$20.3K
GES
1320
DELISTED
Guess Inc
GES
$54K ﹤0.01%
2,275
-755
-25% -$16.7K
KURA icon
1321
Kura Oncology
KURA
$850M
$54K ﹤0.01%
3,860
+710
+23% +$11.5K
PLUS icon
1322
ePlus
PLUS
$2.34B
$54K ﹤0.01%
+1,002
New +$55.3K
SSTK icon
1323
Shutterstock
SSTK
$219M
$54K ﹤0.01%
+483
New +$56.2K
F icon
1324
Ford
F
$55.7B
$53K ﹤0.01%
+2,561
New +$47.1K
NGVT icon
1325
Ingevity
NGVT
$2.68B
$53K ﹤0.01%
+743
New +$56.5K

Similar funds

Point72 Hong Kong's Q4 2021 Portfolio in Review

As of Q4 2021, Point72 Hong Kong held 2,616 positions worth $2.88B, down 6.2% from $3.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Hong Kong withdrew a net $389M in Q4 2021, closing 773 positions and reducing 710 holdings. Its most notable exit was TAL Education Group, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Point72 Hong Kong opened a new position in Riot Platforms worth $20.5M.

  • Point72 Hong Kong's largest Q4 2021 buy was Riot Platforms: 920,169 shares worth $20.5M.
  • Point72 Hong Kong added most to XPeng in Q4 2021, an estimated $75.5M increase.
  • Point72 Hong Kong's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $25.5M.
  • Point72 Hong Kong fully exited TAL Education Group in Q4 2021, selling an estimated $37M.
  • Point72 Hong Kong's ten largest holdings make up 24% of its $2.88B portfolio in Q4 2021.
  • Point72 Hong Kong opened 690 new positions and closed 773 in Q4 2021.
  • Point72 Hong Kong's portfolio value fell 6.2% quarter-over-quarter to $2.88B.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.